Allison Willis, MD, MS
Associate Professor of Neurology
Attending Neurologist, University of Pennsylvania Health System
Faculty Scholar, Center for Clinical Epidemiology and Biostatistics, University of Pennsylvania Perelman School of Medicine
Faculty Scholar, Institute of Aging, University of Pennsylvania Perelman School of Medicine
Senior Scholar, Leonard Davis Institute of Health Economics, University of Pennsylvania School of Medicine
Faculty Scholar, Center for Pharmacoepidemiology Research and Training, University of Pennsylvania Perelman School of Medicine
Co-Director, Resource Center for Minority Aging Research, University of Pennsylvania Perelman School of Medicine
Department: Neurology
Contact information
Blockley Hall, Room 811
423 Guardian Drive
Philadelphia, PA 19104
423 Guardian Drive
Philadelphia, PA 19104
Lab: 2155734983
Education:
MD (Medicine)
University of Illinois College of Medicine, 2002.
MSCI (Master of Science in Clinical Investigation)
Washington University School of Medicine, 2013.
Permanent linkMD (Medicine)
University of Illinois College of Medicine, 2002.
MSCI (Master of Science in Clinical Investigation)
Washington University School of Medicine, 2013.
Selected Publications
Dorsey ER, Greenamyre JT, Willis AW.: The Water, the Air, the Marines-Camp Lejeune, Trichloroethylene, and Parkinson Disease. JAMA Neurol May 2023.Aamodt WW, Willis AW, Dahodwala N.: Racial and Ethnic Disparities in Parkinson Disease: A Call to Action. Neurol Clin Pract 13(2): e200138, Apr 2023.
Hamedani AG, Thibault D, Willis AW.: Seasonal Variation in Neurologic Hospitalizations in the United States. Ann Neurol 93(4): 743-751, Apr 2023.
Abraham DS, Nguyen TPP, Blank LJ, Thibault D, Gray SL, Hennessy S, Leonard CE, Weintraub D, Willis AW.: Channeling of New Neuropsychiatric Drugs-Impact on Safety and Effectiveness Studies. Neurotherapeutics 20(2): 375-388, Mar 2023.
Hernandez-Con P, Shults J, Willis AW, Yang YX.: Dopamine agonists and risk of lung cancer in patients with restless legs syndrome. Pharmacoepidemiol Drug Saf Feb 2023.
Miller-Patterson C, Hsu JY, Willis AW, Hamedani AG.: Functional Impairment in Individuals With Prodromal or Unrecognized Parkinson Disease. JAMA Neurol 80(2): 200-204, Feb 2023.
Acton EK, Willis AW, Hennessy S.: Core concepts in pharmacoepidemiology: Key biases arising in pharmacoepidemiologic studies. Pharmacoepidemiol Drug Saf 32(1): 9-18, Jan 2023.
Miller-Patterson, C., Hsu, J. Y., Chahine, L. M., Morley, J. F., & Willis, A. W.: Selected autonomic signs and symptoms as risk markers for phenoconversion and functional dependence in prodromal Parkinson’s disease. Clinical Autonomic Research 32(6): 463-476, Dec 2022 Notes: Epub ahead of print.
ham Nguyen, T. P., Thibault, D., Hamedani, A. G., Weintraub, D., & Willis, A. W. : Atypical antipsychotic use and mortality risk in Parkinson disease. Parkinsonism & Related Disorders 103: 17-22, Oct 2022 Notes: Epub ahead of print.
Acton EK, Blank LJ, Willis AW, Hamedani AG.: Interfacility Transfers for Seizure-Related Emergencies in the United States. Neurology 99: e2718-27, Oct 2022.